Award
NIH Reporter #5U01CA275310-04
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
Recipient
Not Specified
Award Amount
$676,145.00
Ceiling
$676,145.00
Awarded
August 28, 2025
Identifier
5U01CA275310-04
NIH grant awarded for research on EBV-positive diffuse large B cell lymphomas in persons living with HIV, focusing on mechanisms and targeted therapies, with a project duration from September 1, 2025, to August 31, 2026.
Description
This is a NIH grant opportunity for research on EBV-positive diffuse large B cell lymphomas in persons living with HIV. The project aims to investigate mechanisms and generate paradigms to reveal how EBV contributes to NHL and to develop targeted therapies. The project involves multiple analyses including cell lines, xenografts, and patient-derived samples.